Quarterly report pursuant to Section 13 or 15(d)

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

v3.21.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
 6 Months Ended
Jun. 30, 2021
Accounting Policies [Abstract]  
SCHEDULE OF OTHER CURRENT ASSETS

Other current assets consisted of the following as of June 30, 2021 and December 31, 2020:

 

    June 30, 2021     December 31, 2020  
      (unaudited)          
Lab supply inventory   $ 2,261     $ 2,052  
Prepaid expenses     783       625  
Other     226       45  
Total other current assets   $ 3,270     $ 2,722  
SCHEDULE OF BASIC AND DILUTED NET LOSS PER SHARE

 

                         
    Three Months Ended     Six Months Ended  
    June 30,     June 30,  
    2021     2020     2021     2020  
    (unaudited)     (unaudited)  
Basic weighted average number of  common shares     4,102       4,033       4,095       4,018  
Potential dilutive effect of stock-based awards     -       -       -       -  
Diluted weighted average number of common shares     4,102       4,033       4,095       4,018  
SCHEDULE OF ANTI-DILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE

 

    Three Months Ended     Six Months Ended  
    June 30,     June 30,  
    2021     2020     2021     2020  
    (unaudited)     (unaudited)  
Options     747       638       747       638  
Restricted stock and restricted stock units (RSUs)     373       42       373       42  
Warrants     1,405       1,420       1,405       1,420  
      2,525       2,100       2,525       2,100